Scientists who work with foreign biological specimens face a patchwork of permits that threaten to block their projects, with potentially harmful consequences for the ecosystems they study.

Scientists from countries with fewer resources are pushing collaborators from higher-income countries to shed biases and behaviors that perpetuate social stratification in the research community.

While some academics have called for compensation for assessing other scientists’ work, publishers haven’t warmed to the idea.

COVID-19 has laid bare some of the pitfalls of the relationship between scientific experts and policymakers—but some researchers say there are ways to make it better.

Life sciences professors and other staff make contingency plans for more coronavirus-related disruptions in the coming school year.

Early career researchers face unique challenges when a senior collaborator becomes embroiled in allegations of scientific malpractice.

Speaking a common language is key to a well-integrated team, but guidance is sparse on what—if anything—principal investigators should do about it.

Many preclinical studies carried out in vivo are poorly designed and generate irreproducible data, but efforts to address the problem are on the rise.

Diversity programs are shifting their focus from just providing academic support to creating a learning environment that is more inclusive of people of different backgrounds.

For many, it’s not a question of when senior academics should leave their posts, it’s about how to distribute scarce resources such as grants and faculty positions more fairly.

Scientists are working to maximize the benefits and minimize the costs of sharing.

Some academic institutions are beginning to complement the work of student organizations in addressing mental health problems in graduate school.

Across the US, laboratories are finding creative ways to minimize the amount of plastic they throw away.  

From the difficulty of tracking rare populations to the danger of poachers exploiting distribution data, the complications of studying endangered species require creative solutions from researchers.

Technology and family constraints are making the “ghostdoc” more popular, but the setup is not without costs, researchers say.

In efforts to translate basic-science results into pharmaceuticals and other technologies, success cannot be taken for granted.

From efforts to increase the transparency of the review process to initiatives offering training, there are many attempts underway to make better reviewers out of researchers.

Private funders are starting to support big projects, and they’re rewriting the playbook on fueling scientific research.